25CN-NBOMe: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
{{Short description|A synthetic psychedelic compound}}
{{DISPLAYTITLE:25CN-NBOMe}}
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477318123
| IUPAC_name = 2-(4-cyano-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
| image = 25CN-NBOMe.svg
| width = 200px
| legal_status = Uncontrolled
| routes_of_administration = [[Sublingual administration|Sublingual]], [[Buccal administration|Buccal]], [[Insufflation]]
| CAS_number = 1043868-97-8
| PubChem = 118796326
| ChemSpiderID = 29762256
| C=19
| H=22
| N=2
| O=3
| smiles = COc1ccccc1CNCCc2cc(OC)c(cc2OC)C#N
}}


'''25CN-NBOMe''' is a synthetic psychedelic compound belonging to the [[NBOMe series]]. It is a derivative of the phenethylamine [[2C family]], specifically related to [[2C-CN]].
== 25CN-NBOMe ==
[[File:25CN-NBOMe.svg|thumb|right|Chemical structure of 25CN-NBOMe]]
25CN-NBOMe, also known as 2C-CN-NBOMe, is a synthetic psychedelic compound belonging to the [[NBOMe]] class. It is a derivative of the phenethylamine 2C-CN and is known for its potent hallucinogenic effects. The compound is primarily used in scientific research and has been studied for its interactions with the [[serotonin receptor|5-HT2A receptor]].


==Chemical structure and properties==
== Chemical Structure and Properties ==
25CN-NBOMe is chemically known as 2-(4-cyano-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine. It features a cyano group at the 4-position of the phenyl ring, which distinguishes it from other compounds in the NBOMe series. The presence of methoxy groups at the 2 and 5 positions of the phenyl ring, along with the N-(2-methoxybenzyl) moiety, contributes to its psychoactive properties.
25CN-NBOMe is chemically classified as a substituted phenethylamine. Its full chemical name is 2-(4-cyanophenyl)-N-[(2-methoxyphenyl)methyl]ethanamine. The compound features a cyanide group attached to the phenyl ring, which distinguishes it from other NBOMe compounds. The presence of the methoxy group on the benzyl moiety is characteristic of the NBOMe series, contributing to its high affinity for the 5-HT2A receptor.


==Pharmacology==
== Pharmacology ==
25CN-NBOMe acts as a potent agonist at the [[5-HT2A receptor]], which is a common target for psychedelic compounds. The activation of this receptor is associated with the hallucinogenic effects experienced by users. The compound is known for its high potency, meaning that very small doses can produce significant effects.
The pharmacological effects of 25CN-NBOMe are primarily mediated through its action as a partial agonist at the 5-HT2A receptor, a subtype of the [[serotonin receptor]]. This interaction is responsible for the psychedelic effects experienced by users. The compound is known for its high potency, with active doses in the microgram range, similar to other NBOMe compounds such as [[25I-NBOMe]] and [[25C-NBOMe]].


==Effects==
== Effects ==
The effects of 25CN-NBOMe are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in mood and thought processes. Due to its potency, the effects can be intense and may last several hours.
The effects of 25CN-NBOMe are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in mood and thought patterns. Due to its potency, the effects can be intense and are often unpredictable. Users have reported both positive experiences, such as enhanced creativity and introspection, and negative experiences, such as anxiety and confusion.


==Legal status==
== Legal Status ==
As of the current date, 25CN-NBOMe is not controlled under international drug treaties. However, its legal status may vary by country, and it may be subject to regulation under analog laws or specific national legislation.
The legal status of 25CN-NBOMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Researchers interested in studying the compound typically require special licenses to handle and experiment with it.


==Safety and toxicity==
== Safety and Toxicity ==
The safety profile of 25CN-NBOMe is not well-established, and there is limited information on its toxicity. Users should exercise caution due to its high potency and the potential for adverse effects, especially at higher doses.
The safety profile of 25CN-NBOMe is not well-established, and there is limited data on its toxicity in humans. As with other NBOMe compounds, there is a risk of overdose, which can lead to severe adverse effects, including [[vasoconstriction]], [[seizures]], and [[serotonin syndrome]]. Users are advised to exercise caution and avoid combining it with other substances.


==Related pages==
== Related Pages ==
* [[NBOMe series]]
* [[NBOMe series]]
* [[2C family]]
* [[Psychedelic drug]]
* [[Psychedelic drug]]
* [[5-HT2A receptor]]
* [[Serotonin receptor]]
 
* [[25I-NBOMe]]
==Gallery==
* [[25C-NBOMe]]
<gallery>
File:25CN-NBOMe.svg|Chemical structure of 25CN-NBOMe
</gallery>


[[Category:Psychedelic phenethylamines]]
[[Category:Psychedelic phenethylamines]]
[[Category:Designer drugs]]
[[Category:NBOMe]]

Latest revision as of 04:02, 13 February 2025


25CN-NBOMe[edit]

Chemical structure of 25CN-NBOMe

25CN-NBOMe, also known as 2C-CN-NBOMe, is a synthetic psychedelic compound belonging to the NBOMe class. It is a derivative of the phenethylamine 2C-CN and is known for its potent hallucinogenic effects. The compound is primarily used in scientific research and has been studied for its interactions with the 5-HT2A receptor.

Chemical Structure and Properties[edit]

25CN-NBOMe is chemically classified as a substituted phenethylamine. Its full chemical name is 2-(4-cyanophenyl)-N-[(2-methoxyphenyl)methyl]ethanamine. The compound features a cyanide group attached to the phenyl ring, which distinguishes it from other NBOMe compounds. The presence of the methoxy group on the benzyl moiety is characteristic of the NBOMe series, contributing to its high affinity for the 5-HT2A receptor.

Pharmacology[edit]

The pharmacological effects of 25CN-NBOMe are primarily mediated through its action as a partial agonist at the 5-HT2A receptor, a subtype of the serotonin receptor. This interaction is responsible for the psychedelic effects experienced by users. The compound is known for its high potency, with active doses in the microgram range, similar to other NBOMe compounds such as 25I-NBOMe and 25C-NBOMe.

Effects[edit]

The effects of 25CN-NBOMe are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in mood and thought patterns. Due to its potency, the effects can be intense and are often unpredictable. Users have reported both positive experiences, such as enhanced creativity and introspection, and negative experiences, such as anxiety and confusion.

Legal Status[edit]

The legal status of 25CN-NBOMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Researchers interested in studying the compound typically require special licenses to handle and experiment with it.

Safety and Toxicity[edit]

The safety profile of 25CN-NBOMe is not well-established, and there is limited data on its toxicity in humans. As with other NBOMe compounds, there is a risk of overdose, which can lead to severe adverse effects, including vasoconstriction, seizures, and serotonin syndrome. Users are advised to exercise caution and avoid combining it with other substances.

Related Pages[edit]